VRDN Operating Cash Flow Growth
Viridian Therapeutics Ors Inc · Operating Cash Flow Growth
VRDN Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported-39.74%period ending
VRDN Quarterly Cash from Operations YoY % (123.17% → -39.74%)
Year-over-year change
High-resolution chart · PNG
VRDN operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| -39.737% | |
| -29.1421% | |
| 67.6076% | |
| -24.9682% | |
| -63.648% | |
| -104.8803% | |
| -92.9789% | |
| -73.6808% | |
| -1.8667% | |
| 27.0279% | |
| -11.6268% | |
| -88.6153% | |
| -149.9945% | |
| -194.5205% | |
| -105.8784% | |
| -74.0317% | |
| -23.6142% | |
| -82.3555% | |
| -75.2331% | |
| -133.0913% | |
| -115.5104% | |
| -36.4109% | |
| -20.8814% | |
| 45.02% | |
| 5.3666% | |
| 28.3682% | |
| 4.5138% | |
| -36.2393% | |
| -59.2099% | |
| -60.4266% | |
| -12.8676% | |
| -20.113% | |
| 36.3379% | |
| 10.0452% | |
| -285.8817% | |
| -403.8256% | |
| -252.49% | |
| -268.2718% | |
| -44.4958% | |
| 51.2153% | |
| 8.1427% | |
| -100.3607% | |
| -30.3236% | |
| -177.2473% | |
| -364.7% | |
| -1,401.8265% | |
| -178.7753% | |
| -180.5855% | |
| -221.3717% | |
| 123.1681% |